1
|
Baggieri M, Gioacchini S, Borgonovo G, Catinella G, Marchi A, Picone P, Vasto S, Fioravanti R, Bucci P, Kojouri M, Giuseppetti R, D'Ugo E, Ubaldi F, Dallavalle S, Nuzzo D, Pinto A, Magurano F. Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2. Biomed Pharmacother 2023; 168:115682. [PMID: 37832410 DOI: 10.1016/j.biopha.2023.115682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 10/06/2023] [Accepted: 10/08/2023] [Indexed: 10/15/2023] Open
Abstract
Natural products are a rich source of bioactive molecules that have potential pharmacotherapeutic applications. In this study, we focused on Artemisia annua (A. annua) and its enriched extracts which were biologically evaluated in vitro as virucidal, antiviral, and antioxidant agents, with a potential application against the COVID-19 infection. The crude extract showed virucidal, antiviral and antioxidant effects in concentrations that did not affect cell viability. Scopoletin, arteannuin B and artemisinic acid (single fractions isolated from A. annua) exerted a considerable virucidal and antiviral effect in vitro starting from a concentration of 50 µg/mL. Data from Surface Plasmon Resonance (SPR) showed that the inhibition of the viral infection was due to the interaction of these compounds with the 3CLpro and Spike proteins of SARS-CoV-2, suggesting that the main interaction of compounds may interfere with the viral pathways during the insertion and the replication process. The present study suggests that natural extract of A. annua and its components could have a key role as antioxidants and antiviral agents and support the fight against SARS-CoV-2 variants and other possible emerging Coronaviruses.
Collapse
Affiliation(s)
- Melissa Baggieri
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Silvia Gioacchini
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Gigliola Borgonovo
- Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente, DeFENS, Università degli Studi di Milano, Via Celoria 2, 20133 Milano, Italy
| | - Giorgia Catinella
- Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente, DeFENS, Università degli Studi di Milano, Via Celoria 2, 20133 Milano, Italy
| | - Antonella Marchi
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Pasquale Picone
- Istituto per la Ricerca e l'Innovazione Biomedica, Consiglio Nazionale delle Ricerche, Via U. La Malfa 153, 0146 Palermo, Italy
| | - Sonya Vasto
- Istituto per la Ricerca e l'Innovazione Biomedica, Consiglio Nazionale delle Ricerche, Via U. La Malfa 153, 0146 Palermo, Italy; Dipartimento di Scienze Biologiche, Chimiche, Farmaceutiche e Tecnologiche, STEBICEF, Università degli Studi di Palermo, Viale delle Scienze, 90128 Palermo, Italy
| | - Raoul Fioravanti
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Paola Bucci
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Maedeh Kojouri
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Roberto Giuseppetti
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | - Emilio D'Ugo
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy
| | | | - Sabrina Dallavalle
- Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente, DeFENS, Università degli Studi di Milano, Via Celoria 2, 20133 Milano, Italy
| | - Domenico Nuzzo
- Istituto per la Ricerca e l'Innovazione Biomedica, Consiglio Nazionale delle Ricerche, Via U. La Malfa 153, 0146 Palermo, Italy
| | - Andrea Pinto
- Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente, DeFENS, Università degli Studi di Milano, Via Celoria 2, 20133 Milano, Italy
| | - Fabio Magurano
- Istituto Superiore di Sanità, Dipartimento di Malattie Infettive, Viale Regina Elena 299, 00161 Roma, Italy.
| |
Collapse
|
2
|
Dallolio L, Gallè F, Masini A, Valeriani F, Ceciliani A, di Cagno A, Galeone D, Pecoraro P, Valerio G, Liguori G, Romano Spica V, Brandi G, Baldelli G, Capelli G, Coco D, Corradi M, Cortis E, Deiana P, Di Rosa E, Marini S, Mulato R, Parisi A, Pesce C, Riegger S, Staiano A, Siniscalco A, Trombetta M, Ubaldi F. Active breaks: a strategy to counteract sedentary behaviors for Health Promoting Schools. A discussion on their implementation in Italy. Ann Ig 2023; 35:202-212. [PMID: 35788249 DOI: 10.7416/ai.2022.2532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Abstract School Active Breaks are short bouts of physical activity (5-15 minutes) conducted by appropriately trained teachers and delivered during or between curricular lessons. They are a good strategy to counteract sedentary behaviors, and a growing body of evidence shows that they can represent also a tool to promote and improve health, school wellbeing and academic achievements. On 19 February 2022, the Working Group on Movement Sciences for Health of the Italian Society of Hygiene, Preventive Medicine and Public Health organized an Awareness Day on the effectiveness, usefulness and feasibility of School Active Breaks, opened to teachers, educators, school leaders, pediatricians, personnel from Departments of Prevention and Public Health and Health Policy-makers. During the event, the testimonies about the experiences already carried out in Italy showed that School Active Breaks are an effective intervention that each school can easily include in its educational offer and apply in any context.
Collapse
Affiliation(s)
- L Dallolio
- Department of Biomedical and Neuromotor Science, University of Bologna, Bologna, Italy
| | - F Gallè
- Department of Movement Sciences and Wellbeing, University of Naples "Parthenope", Italy
| | - A Masini
- Department of Biomedical and Neuromotor Science, University of Bologna, Bologna, Italy
| | - F Valeriani
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - A Ceciliani
- Department for Life Quality Studies, University of Bologna, Bologna, Italy
| | - A di Cagno
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - D Galeone
- General Directorate for Health Prevention, Ministry of Health, Rome, Italy
| | - P Pecoraro
- Local Health Agency Naples 3 South, Naples, Italy
| | - G Valerio
- Department of Movement Sciences and Wellbeing, University of Naples "Parthenope", Italy
| | - G Liguori
- Department of Movement Sciences and Wellbeing, University of Naples "Parthenope", Italy
| | - V Romano Spica
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - G Brandi
- Department of Biomolecular Sciences, Public Health Unit, University "Carlo Bo", Urbino, Italy
| | - G Baldelli
- School Active Breaks awareness day, Italy.,Department of Biomolecular Sciences, Public Health Unit, University "Carlo Bo", Urbino, Italy
| | - G Capelli
- School Active Breaks awareness day, Italy.,National Centre for Diseases Prevention and Health Promotion, National Institutes of Health, Rome, Italy
| | - D Coco
- School Active Breaks awareness day, Italy.,Department of Education, University of Rome "Roma Tre", Rome, Italy
| | - M Corradi
- School Active Breaks awareness day, Italy.,Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy
| | - E Cortis
- School Active Breaks awareness day, Italy.,Pediatric Unit, Sant'Eugenio Hospital, ASL Rome 2, Rome, Italy
| | - P Deiana
- School Active Breaks awareness day, Italy.,Office of School Sport Policies, Italian Ministry of Education, Rome, Italy
| | - E Di Rosa
- School Active Breaks awareness day, Italy.,Office of School Sport Policies, Italian Ministry of Education, Rome, Italy
| | - S Marini
- Department for Life Quality Studies, University of Bologna, Bologna, Italy.,School Active Breaks awareness day, Italy
| | - R Mulato
- School Active Breaks awareness day, Italy.,Moving School 21 ONLUS, Bologna, Italy
| | - A Parisi
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.,School Active Breaks awareness day, Italy
| | - C Pesce
- School Active Breaks awareness day, Italy.,Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - S Riegger
- School Active Breaks awareness day, Italy.,Moving School 21 ONLUS, Bologna, Italy
| | - A Staiano
- School Active Breaks awareness day, Italy.,Department of Translational Science, University of Naples, Federico II, Naples, and Italian Society of Pediatrics (SIP), Italy
| | - A Siniscalco
- School Active Breaks awareness day, Italy.,Dinamica Tai Chi Chuan e Arti associate A.S.D., Rome, Italy
| | - M Trombetta
- School Active Breaks awareness day, Italy.,"FairPlay4U" Educational Project for School, Galatea Communications, Rome, Italy
| | - F Ubaldi
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.,School Active Breaks awareness day, Italy
| |
Collapse
|
3
|
Maggiulli R, Cimadomo D, Dovere L, Innocenti F, Albricci L, Soscia D, Giancani A, Sanges F, Amendola MG, Tacconi L, Nastri G, Morgante V, Vaiarelli A, Ubaldi F, Rienzi L. P–783 Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is cryo-storage duration associated with the outcomes after vitrified-warmed euploid single blastocyst transfer?
Summary answer
Lower live-birth-rates from blastocysts cryo-stored for periods longer than 3-months are mostly imputable to the worse quality of the embryos being warmed across sequential transfers.
What is known already
Blastocyst vitrification is crucial in modern IVF. Given its widespread application, a constant comprehensive monitoring of its effect on reproductive outcomes is pivotal. For instance, the effect of cryo-storage duration on embryo implantation potential, gestational and perinatal outcomes is object of a still ongoing investigation. The evidence in this regard are contrasting especially with regard to similar or decreased live birth rates among blastocysts subject to long-term cryo-storage. When investigating the neonatal outcomes, instead, no impact of blastocyst cryo-storage duration has ever been reported to date. Yet, data on euploid blastocysts and adjusted for quality and full-blastulation day are needed.
Study design, size, duration
Retrospective observational study. We included 2688 vitrified-warmed euploid single blastocyst transfers. The primary outcome was the live-birth-rates (LBR) according to cryo-storage duration clustered as ≤ 60, 61–90, 91–180, 181–360, 361–720, 721–1080 and >1080-days. The secondary outcomes were the miscarriage rate, the rates of gestational and perinatal issues among the deliveries, and the mean gestational age and birthweight among the babies born. All data were adjusted for confounders through linear or logistic regression analyses. Participants/materials, setting, methods: We included all vitrified-warmed transfers (range:1–8) conducted between May–2013 and March–2020 by 1884 patients (age:38±3yr) undergoing one blastocyst stage PGT-A cycle and obtaining ≥1 euploid embryo at our private clinic. Among putative confounders, only the number of sequential transfer from the same patient, blastocyst quality (Gardner’s scheme) and full-blastulation day (5–7) significantly associated with the LBR through univariate regressions. No association was reported for sperm factor, maternal age, incubator, and culture media.
Main results and the role of chance
The LBR of euploid blastocysts cryo-stored for ≤60-days was 49.4% (N = 319/646) versus 48.7% (N = 292/599; OR:0.98,95%CI:0.78–1.21,p=0.82) between 61–90-days, 42.9% (N = 291/679; OR:0.77,95%CI:0.62–0.96,p=0.02) between 91–180-days, 41.7% (N = 169/405; OR:0.73,95%CI:0.57–0.94,p=0.02) between 181–360-days, 34.7% (N = 50/144; OR:0.55,95%CI:0.37–0.79,p<0.01) between 361–720-days, 53.4% (N = 63/118; OR:1.17,95%CI:0.79–1.74,p=0.42) between 721–1080-days, and 50.5% (N = 49/97; OR:1.05,95%CI:0.68–1.60,p=0.83) for >1080-days. However, when these data were adjusted for blastocyst quality and full-blastulation day, all the multivariate-OR were not-significant. Indeed, the longer the cryo-storage period the worse the quality of the euploid blastocysts transferred (e.g. AA-blastocysts were 74% among embryos cryo-stored for ≤90-days, but always <70% for embryos cryo-stored for longer periods, p < 0.01; similarly, day5-blastocysts were ∼50% among embryos cryo-stored for ≤90-days, but always <50% for embryos cryo-stored for longer periods, p = 0.02). The miscarriage-rate (overall 14%, ranging 7–18%) was not associated with cryo-storage duration already from univariate regressions. Also the gestational (overall 6%, ranging 0–8%) and perinatal issues rates (overall 3%, ranging 0–5%) were not associated with cryo-storage duration already from the univariate regressions. Neither the gestational age nor the birthweight showed significant associations with cryo-storage duration, as confirmed by linear regressions. In fact the rate of newborns whose weight was normal-for-gestational-age was similar across all cryo-storage duration groups (overall 81%, ranging 80–83%).
Limitations, reasons for caution
The prevalence of first transfers decreases from ≥95% for procedures conducted ≤90-days from vitrification to 71%, 39%, 22% and 4% for procedures conducted between 91–180, 181–360, 361–720 and >720-days, respectively. However, also the sequential number of transfer was not associated with the LBR when adjusted for blastocyst-quality and full-blastulation day.
Wider implications of the findings: Cryo-storage by vitrification is confirmed safe in the hands of experienced operators, and its duration does not impact any outcome. This information is valuable for freeze-all cycles, but also for women cryo-preserving surplus embryos for second pregnancies; in this regard, 6.8% of the patients in this study delivered ≥2 LBs.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- R Maggiulli
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - D Cimadomo
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Dovere
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Innocenti
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Albricci
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - D Soscia
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - A Giancani
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Sanges
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - M G Amendola
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Tacconi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - G Nastri
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - V Morgante
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - A Vaiarelli
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Ubaldi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Rienzi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| |
Collapse
|
4
|
Forte M, Faustini F, Venturella R, Rania E, Alviggi E, Trabucco E, Cimadomo D, Capalbo A, Zullo F, Ubaldi F, Rienzi L. P–500 Euploid embryo-transfer reduces advanced maternal age patients’ anxiety in the waiting period before the pregnancy-test. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Study question
Can PGT-A reduce the anxiety generally experienced by infertile women undergoing IVF in the waiting period between embryo transfer and the pregnancy test?
Summary answer
PGT-A reduces anxiety in infertile women after embryo transfer, probably due to a gain of confidence in their treatment route.
What is known already
The waiting period, i.e. the time between embryo-transfer and the pregnancy-test, is considered unpredictable and unmanageable, thus figuring amongst the most stressful steps of an IVF treatment. This is mainly imputable to women’s lost sense of control over the outcome. Uncertainty is in fact a source of fear and elevated distress. PGT-A has been shown to improve live birth rate per embryo transfer and reduce miscarriage rate per clinical pregnancy across several trials and observational studies worldwide, especially in advanced maternal age (AMA) women. Here, we investigated if euploid embryo transfer does involve also lower emotional burden over untested one.
Study design, size, duration
Prospective observational study evaluating the level of anxiety in the waiting period among women undergoing euploid or untested embryo transfer. Data were collected between September 2019 and September 2020 in a public hospital. A total of 48 infertile women were recruited: 25 undergoing euploid single embryo transfer after trophectoderm biopsy and NGS, and 23 undergoing untested single embryo transfer.
Participants/materials, setting, methods
To measure the level of anxiety, the two groups completed the STAI (State Trait Anxiety Inventory) questionnaire at two time points: before starting the ovarian stimulation (T0), and at day 8 after embryo transfer (T1). The chosen questionnaire has been previously validated to capture the level of patients’ anxiety during the waiting period. Outcomes of T0 were used to control for individual level state of anxiety at T1.
Main results and the role of chance
The two groups showed similar reproductive history and sociodemographic characteristics except for female age, which was higher in the PGT-A group (37.7±3.2 yr versus 32.3±2.2 yr in the control). This is due to AMA (maternal age >35 yr) being the main indication to PGT-A. Conversely, the duration of infertility was similar in the two groups (3.8±2.2 yr versus 3.7±1.9 in the control). At T0 all patients showed similar levels of anxiety (46.4 points versus 49.9 in the control, 95%CI of the difference: from –9.97 to 3.03 points, p = 0.3). Remarkably, at T1 instead, the women undergoing euploid embryo transfer showed a significantly decreased level of anxiety with respect to the control (39.9 points versus 53.4; 95% CI of the difference: from –18.26 to –8.69, p < 0.01). This difference remained significant also after controlling for the baseline value at T0, and adjusting for potential confounding factors in a multivariate analysis (adjusted p-value<0.01).
Limitations, reasons for caution
The sample size is small, yet the study resulted powered enough to reveal the considerable advantage of PGT-A toward the primary outcome. We analysed only the waiting period here. Therefore, data will be collected in the future at subsequent gestational stages, such as when prenatal genetic diagnosis is usually conducted.
Wider implications of the findings: Women undergoing PGT-A seem reassured by the technique. This is probably due to the gain of confidence and control derived from an increased expectation of success. From this perspective, assessing women’s wellbeing and attitude towards all different clinical procedures should become a critical part of their treatment.
Trial registration number
None
Collapse
Affiliation(s)
- M Forte
- GENERALife, Reproductive Medicine, Rome, Italy
| | | | - R Venturella
- ART Center- Azienda Ospedaliera Pugliese-Ciaccio, Department of Obstetrics and Gynecology- ART Center- Azienda Ospedaliera Pugliese-Ciaccio- Catanzaro, Catanzaro, Italy
| | - E Rania
- ART Center- Azienda Ospedaliera Pugliese-Ciaccio, Department of Obstetrics and Gynecology, Catanzaro, Italy
| | - E Alviggi
- Ruesch Clinic- GeneraLife IVF, Reproductive medicine, Naples, Italy
| | - E Trabucco
- Ruesch Clinic- GeneraLife IVF, Reproductive medicine, Naples, Italy
| | - D Cimadomo
- GENERALife, Reproductive Medicine, Rome, Italy
| | - A Capalbo
- Igenomix, Reproductive Genetics, Marostica, Italy
| | - F Zullo
- ART Center- Azienda Ospedaliera Pugliese-Ciaccio, Department of Obstetrics and Gynecology, Catanzaro, Italy
| | - F Ubaldi
- GENERALife, Reproductive Medicine, Rome, Italy
| | - L Rienzi
- GENERALife, Reproductive Medicine, Rome, Italy
| |
Collapse
|
5
|
Maggiulli R, Cimadomo D, Dovere L, Innocenti F, Albricci L, Soscia D, Giancani A, Sanges F, Amendola MG, Tacconi L, Nastri G, Morgante V, Vaiarelli A, Ubaldi F, Rienzi L. P-783 Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration. Hum Reprod 2021. [DOI: 10.1093/humrep/deab125.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is cryo-storage duration associated with the outcomes after vitrified-warmed euploid single blastocyst transfer?
Summary answer
Lower live-birth-rates from blastocysts cryo-stored for periods longer than 3-months are mostly imputable to the worse quality of the embryos being warmed across sequential transfers.
What is known already
Blastocyst vitrification is crucial in modern IVF. Given its widespread application, a constant comprehensive monitoring of its effect on reproductive outcomes is pivotal. For instance, the effect of cryo-storage duration on embryo implantation potential, gestational and perinatal outcomes is object of a still ongoing investigation. The evidence in this regard are contrasting especially with regard to similar or decreased live birth rates among blastocysts subject to long-term cryo-storage. When investigating the neonatal outcomes, instead, no impact of blastocyst cryo-storage duration has ever been reported to date. Yet, data on euploid blastocysts and adjusted for quality and full-blastulation day are needed.
Study design, size, duration
Retrospective observational study. We included 2688 vitrified-warmed euploid single blastocyst transfers. The primary outcome was the live-birth-rates (LBR) according to cryo-storage duration clustered as ≤ 60, 61-90, 91-180, 181-360, 361-720, 721-1080 and >1080-days. The secondary outcomes were the miscarriage rate, the rates of gestational and perinatal issues among the deliveries, and the mean gestational age and birthweight among the babies born. All data were adjusted for confounders through linear or logistic regression analyses.
Participants/materials, setting, methods
We included all vitrified-warmed transfers (range:1-8) conducted between May-2013 and March-2020 by 1884 patients (age:38±3yr) undergoing one blastocyst stage PGT-A cycle and obtaining ≥1 euploid embryo at our private clinic. Among putative confounders, only the number of sequential transfer from the same patient, blastocyst quality (Gardner’s scheme) and full-blastulation day (5-7) significantly associated with the LBR through univariate regressions. No association was reported for sperm factor, maternal age, incubator, and culture media.
Main results and the role of chance
The LBR of euploid blastocysts cryo-stored for ≤60-days was 49.4% (N = 319/646) versus 48.7% (N = 292/599; OR:0.98,95%CI:0.78-1.21,p = 0.82) between 61-90-days, 42.9% (N = 291/679; OR:0.77,95%CI:0.62-0.96,p = 0.02) between 91-180-days, 41.7% (N = 169/405; OR:0.73,95%CI:0.57-0.94,p = 0.02) between 181-360-days, 34.7% (N = 50/144; OR:0.55,95%CI:0.37-0.79,p < 0.01) between 361-720-days, 53.4% (N = 63/118; OR:1.17,95%CI:0.79-1.74,p = 0.42) between 721-1080-days, and 50.5% (N = 49/97; OR:1.05,95%CI:0.68-1.60,p = 0.83) for >1080-days. However, when these data were adjusted for blastocyst quality and full-blastulation day, all the multivariate-OR were not-significant. Indeed, the longer the cryo-storage period the worse the quality of the euploid blastocysts transferred (e.g. AA-blastocysts were 74% among embryos cryo-stored for ≤90-days, but always < 70% for embryos cryo-stored for longer periods, p < 0.01; similarly, day5-blastocysts were ∼50% among embryos cryo-stored for ≤90-days, but always < 50% for embryos cryo-stored for longer periods, p = 0.02). The miscarriage-rate (overall 14%, ranging 7-18%) was not associated with cryo-storage duration already from univariate regressions. Also the gestational (overall 6%, ranging 0-8%) and perinatal issues rates (overall 3%, ranging 0-5%) were not associated with cryo-storage duration already from the univariate regressions. Neither the gestational age nor the birthweight showed significant associations with cryo-storage duration, as confirmed by linear regressions. In fact the rate of newborns whose weight was normal-for-gestational-age was similar across all cryo-storage duration groups (overall 81%, ranging 80-83%).
Limitations, reasons for caution
The prevalence of first transfers decreases from ≥95% for procedures conducted ≤90-days from vitrification to 71%, 39%, 22% and 4% for procedures conducted between 91-180, 181-360, 361-720 and >720-days, respectively. However, also the sequential number of transfer was not associated with the LBR when adjusted for blastocyst-quality and full-blastulation day.
Wider implications of the findings
Cryo-storage by vitrification is confirmed safe in the hands of experienced operators, and its duration does not impact any outcome. This information is valuable for freeze-all cycles, but also for women cryo-preserving surplus embryos for second pregnancies; in this regard, 6.8% of the patients in this study delivered ≥2 LBs.
Trial registration number
not applicable
Collapse
Affiliation(s)
- R Maggiulli
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - D Cimadomo
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Dovere
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Innocenti
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Albricci
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - D Soscia
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - A Giancani
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Sanges
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - M G Amendola
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Tacconi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - G Nastri
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - V Morgante
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - A Vaiarelli
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - F Ubaldi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| | - L Rienzi
- Clinica Valle Giulia, GeneraLife IVF, Rome, Italy
| |
Collapse
|
6
|
Gallè F, Valeriani F, Cattaruzza MS, Ubaldi F, Romano Spica V, Liguori G. Exploring the association between physical activity and gut microbiota composition: a review of current evidence. Ann Ig 2020; 31:582-589. [PMID: 31616902 DOI: 10.7416/ai.2019.2318] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The gut microbiota is implicated in digestive, metabolic and immune processes of the host. The physiological and pathophysiological functions of the intestinal microbiota depend of its composition, and several individual or external factors may be associated with the presence of some categories, phyla or species of microorganisms in the gut. In particular, two bacterial phyla - Firmicutes and Bacteroidetes - are predominant in the human gut and their relative concentrations seem to be related with age, gender, diet habits and weight status. In the last decade, several studies have tried to characterize the possible role of physical activity in determining qualitative and quantitative composition of the intestinal microbiota. This review is aimed at exploring the current evidences regarding the association between physical activity and gut microbiota composition in animal models and in the humans. Further studies are needed to clarify the mutual relationships among exercise, diet, nutritional supplements/doping agents and gut microbiota.
Collapse
Affiliation(s)
- F Gallè
- Department of Movement Sciences and Wellbeing, University of Naples "Parthenope", Naples, Italy
| | - F Valeriani
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - M S Cattaruzza
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
| | - F Ubaldi
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy
| | - V Romano Spica
- Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy - WDPP, Working Group on Doping Prevention Project - GSMS-SItI, Working Group on Movement Sciences for Health, Italian Society of Hygiene, Preventive Medicine and Public Health
| | - G Liguori
- Department of Movement Sciences and Wellbeing, University of Naples "Parthenope", Naples, Italy - WDPP, Working Group on Doping Prevention Project - GSMS-SItI, Working Group on Movement Sciences for Health, Italian Society of Hygiene, Preventive Medicine and Public Health
| | | | | |
Collapse
|
7
|
Rubio Lluesa C, Rienzi L, Navarro Sanchez L, Cimadomo D, Garcia-Pascual C, Soscia D, Martinez-Merino L, Capalbo A, Ubaldi F, Simon C. Origin of false positives and false negatives in non-invasive preimplantation genetic testing for aneuploidies. Fertil Steril 2018. [DOI: 10.1016/j.fertnstert.2018.07.1182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
8
|
Tejera A, Stoppa M, Meseguer M, Capalbo A, Florensa M, Ubaldi F, Galiana Y, Rienzi L. Description of euploid embryo implantation outcome by morphokinetic investigation. Fertil Steril 2015. [DOI: 10.1016/j.fertnstert.2015.07.889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
9
|
Thornhill A, Dibouni ZA, Shah T, Wheat S, Teitelbaum M, Walker M, Bissonette F, Yuzpe AL, Leveille MC, Gysler M, Johnson M, Sprague A, Villena JG, Aparicio JL, Gimenez J, Ten J, Perez RB, Scholten I, Chambers GM, van Loendersloot L, van der Veen F, Repping S, Gianotten J, Hompes PGA, Ledger W, Mol BWJ, Dior UP, Laufer N, Granovsky-Grisaru S, Yagel S, Yaffe H, Gielchinsky Y, Nelen WLDM, Huppelschoten AG, Verkerk EW, Adang EMM, Kremer JAM, Davies M, Rumbold A, Marino J, Willson K, Moore V, Giles L, Shebl O, Ebner T, Tews G, Haas D, Oppelt P, Mayer RB, Sanges F, Maggiulli R, Albricci L, Romano S, Scarica C, Schimberni M, Giallonardo A, Vettraino G, Ubaldi F, Rienzi L, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Obrado EC, Barredo DR, Navarro LL, Rodriguez AV, Rague PNB, Lletget BC, Padro RT, Oron G, Sokal-Arnon T, Zeadna A, Son WY, Holzer H, Tulandi T, Nakamura Y, Hattori H, Sato Y, Kuchiki M, Sakamoto E, Doshida M, Toya M, Kyono K, Nakajo Y, Nakamura Y, Hirata K, Doshida M, Toya M, Kyono K, Xin ZM, Zhu H, Sun YP, Jin HX, Song WY, Rodriguez A, Poisot F, Rodriguez F, Coll O, Vassena R, Vernaeve V, Ye Y, Wang L, Wang N, Le F, Jin F, Zheng Y, Jin F, Lou Y, Le F, Pan PP, Wang N, Wang LY, Hu CX, Liu SY, Zheng YM, Li LJ, Liu XZ, Xu XR, Huang HF, Jin F, Lin SL, Li M, Lian Y, Chen LX, Liu P, Kawwass JF, Crawford S, Kissin DM, Session DR, Boulet S, Jamieson DJ. Quality and safety of ART therapies. Hum Reprod 2013. [DOI: 10.1093/humrep/det219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Furia GU, Kostelijk EH, Vergouw CG, Lee H, Lee S, Park D, Kang H, Lim C, Yang K, Lee S, Lim C, Park Y, Shin M, Yang K, Lee H, Beyhan Z, Fisch JD, Sher G, Keskintepe L, VerMilyea MD, Anthony JT, Graham JR, Tucker MJ, Tucker MJ, Freour T, Lattes S, Lammers J, Mansour W, Jean M, Barriere P, El Danasouri I, Gagsteiger F, Rinaldi L, Selman H, Antonova I, Milachich T, Valkova L, Shterev A, Barcroft J, Dayoub N, Thong J, Abdel Reda H, Khalaf Y, El Touky T, Cabry R, Brzakowski R, Lourdel E, Brasseur F, Copin H, Merviel P, Yamada M, Takanashi K, Hamatani T, Akutsu H, Fukunaga T, Inoue O, Ogawa S, Sugawara K, Okumura N, Chikazawa N, Kuji N, Umezawa A, Tomita M, Yoshimura Y, Van der Jeught M, Ghimire S, O'Leary T, Lierman S, Deforce D, Chuva de Sousa Lopes S, Heindryckx B, De Sutter P, Herrero J, Tejera A, De los Santos MJ, Castello D, Romero JL, Meseguer M, Barriere P, Lammers J, Lattes S, Leperlier F, Mirallie S, Jean M, Freour T, Schats R, Al-Nofal M, Vergouw CG, Lens JW, Rooth H, Kostelijk EH, Hompes PG, Lambalk CB, Hreinsson J, Karlstrom PO, Wanggren K, Lundqvist M, Vahabi Z, Eftekhari-Yazdi P, Dalman A, Ebrahimi B, Daneshzadeh MT, Rajabpour Niknam M, Choi EG, Rho YH, Oh DS, Park LS, Cheon HS, Lee CS, Kong IK, Lee SC, Liebenthron J, Montag M, Koster M, Toth B, Reinsberg J, van der Ven H, Strowitzki T, Morita H, Hirosawa T, Watanabe S, Wada T, Kamihata M, Kuwahata A, Ochi M, Horiuchi T, Fatemeh H, Eftekhari-Yazdi P, Karimian L, Fazel M, Fouladi H, Johansson L, Ruttanajit T, Chanchamroen S, Sopaboon P, Seweewanlop S, Sawakwongpra K, Jindasri P, Jantanalapruek T, Charoonchip K, Vajta G, Quangkananurug W, Yi G, Jo JW, Jee BC, Suh CS, Kim SH, Zhang Y, Zhao HJ, Cui YG, Gao C, Gao LL, Liu JY, Sozen E, Buluc B, Vicdan K, Akarsu C, Tuncay G, Hambiliki F, Bungum M, Agapitou K, Makrakis E, Liarmakopoulou S, Anagnostopoulou C, Moustakarias T, Giannaris D, Wang J, Andonov M, Linara E, Charleson C, Ahuja KK, Ozsoy S, Morris MB, Day ML, Cobo A, Castello D, Viloria T, Campos P, Vallejo B, Remohi J, Roldan M, Perez-Cano I, Cruz M, Martinez M, Gadea B, Munoz M, Garrido N, Meseguer M, Mesut N, Ciray HN, Mesut A, Isler A, Bahceci M, Munoz M, Fortuno S, Legidos V, Muela L, Roldan M, Galindo N, Cruz M, Meseguer M, Gunasheela S, Gunasheela D, Ueno S, Uchiyama K, Kondo M, Ito M, Kato K, Takehara Y, Kato O, Edgar DH, Krapez JA, Bacer Kermavner L, Virant-Klun I, Pinter B, Tomazevic T, Vrtacnik-Bokal E, Lee SG, Kang SM, Lee SW, Jeong HJ, Lee YC, Lim JH, Bochev I, Valkova L, Kyurkchiev S, Shterev A, Wilding M, Coppola G, Di Matteo L, Dale B, Hormann-Kropfl M, Kastelic D, Montag M, Schenk M, Fourati Ben Mustapha S, Khrouf M, Braham M, Kallel L, Elloumi H, Merdassi G, Chaker A, Ben Meftah M, Zhioua F, Zhioua A, Kocent J, Neri QV, Rosenwaks Z, Palermo GD, Best L, Campbell A, Fishel S, Calimlioglu N, Sahin G, Akdogan A, Susamci T, Bilgin M, Goker ENT, Tavmergen E, Cantatore C, Ding J, Depalo R, Smith GD, Kasapi E, Panagiotidis Y, Papatheodorou A, Goudakou M, Pasadaki T, Nikolettos N, Asimakopoulos B, Prapas Y, Soydan E, Gulebenzer G, Karatekelioglu E, Budak E, Pehlivan Budak T, Alegretti J, Cuzzi J, Negrao PM, Moraes MP, Bueno MB, Serafini P, Motta ELA, Elaimi A, Harper JC, Stecher A, Baborova P, Wirleitner B, Schwerda D, Vanderzwalmen P, Zech NH, Stanic P, Hlavati V, Gelo N, Pavicic-Baldani D, Sprem-Goldstajn M, Radakovic B, Kasum M, Strelec M, Simunic V, Vrcic H, Khan I, Urich M, Abozaid T, Ullah K, Abuzeid M, Fakih M, Shamma N, Ayers J, Ashraf M, Milik S, Pirkevi C, Atayurt Z, Yazici S, Yelke H, Kahraman S, Dal Canto M, Coticchio G, Brambillasca F, Mignini Renzini M, Novara P, Maragno L, Karagouga G, De Ponti E, Fadini R, Resta S, Magli MC, Cavallini G, Muzzonigro F, Ferraretti AP, Gianaroli L, Barberi M, Orlando G, Sciajno R, Serrao L, Fava L, Preti S, Bonu MA, Borini A, Varras M, Polonifi A, Mantzourani M, Mavrogianni D, Stefanidis K, Griva T, Bletsa R, Dinopoulou V, Drakakis P, Loutradis D, Campbell A, Hickman CFL, Duffy S, Bowman N, Gardner K, Fishel S, Sati L, Zeiss C, Demir R, McGrath J, Yelke H, Atayurt Z, Yildiz S, Unal S, Kumtepe Y, Kahraman S, Atayurt Z, Yelke H, Unal S, Kumtepe Y, Kahraman S, Aljaser F, Hernandez J, Tomlinson M, Campbell B, Fosas N, Redondo Ania M, Marina F, Molfino F, Martin P, Perez N, Carrasco A, Garcia N, Gonzalez S, Marina S, Redondo Ania M, Marina F, Molfino F, Fosas N, Martin P, Perez N, Carrasco A, Garcia N, Gonzalez S, Marina S, Scaruffi P, Stigliani S, Tonini GP, Venturini PL, Anserini P, Guglielmo MC, Coticchio G, Albertini DF, Dal Canto M, Brambillasca F, Lain M, Caliari I, Mignini Renzini M, Fadini R, Oikonomou Z, Chatzimeletiou K, Sioga A, Oikonomou L, Kolibianakis E, Tarlatzis B, Nottola SA, Bianchi V, Lorenzo C, Maione M, Macchiarelli G, Borini A, Gomez E, Gil MA, Sanchez-Osorio J, Maside C, Martinez MJ, Torres I, Rodenas C, Cuello C, Parrilla I, Molina G, Garcia A, Margineda J, Navarro S, Roca J, Martinez EA, Avcil F, Ozden H, Candan ZN, Uslu H, Karaman Y, Gioacchini G, Giorgini E, Carnevali O, Bianchi V, Ferraris P, Vaccari L, Borini A, Choe S, Tae J, Kim C, Lee J, Hwang D, Kim K, Suh C, Jee B, Ozden H, Candan ZN, Avcil F, Uslu H, Karaman Y, Catt SL, Sorenson H, Vela M, Duric V, Chen P, Temple-Smith PD, Pangestu M, Yoshimura T, Fukunaga N, Nagai R, Kitasaka H, Tamura F, Hasegawa N, Kato M, Nakayama K, Takeuchi M, Aoyagi N, Yasue K, Watanabe H, Asano E, Hashiba Y, Asada Y, Iwata K, Yumoto K, Mizoguchi C, Sargent H, Kai Y, Ueda M, Tsuchie Y, Imajo A, Iba Y, Mio Y, Els-Smit CL, Botha MH, Sousa M, Windt-De Beer M, Kruger TF, Muller N, Magli C, Corani G, Giusti A, Castelletti E, Gambardella L, Gianaroli L, Seshadri S, Sunkara SK, El-Toukhy T, Kishi I, Maruyama T, Ohishi M, Akiba Y, Asada H, Konishi Y, Nakano M, Kamei K, Yoshimura Y, Lee JH, Lee KH, Park IH, Sun HG, Kim SG, Kim YY, Choi EM, Lee DH, Chavez SL, Loewke KE, Behr B, Han J, Moussavi F, Reijo Pera RA, Yokota H, Yokota Y, Yokota M, Sato S, Nakagawa M, Sato M, Anazawa I, Araki Y, Virant-Klun I, Knez K, Pozlep B, Tomazevic T, Vrtacnik-Bokal E, Lim JH, Vermilyea MD, Graham JR, Levy MJ, Tucker MJ, Carvalho M, Cordeiro I, Leal F, Aguiar A, Nunes J, Rodrigues C, Soares AP, Sousa S, Calhaz-Jorge C, Braga DPAF, Setti AS, Figueira RCS, Aoki T, Iaconelli A, Borges E, Ozkavukcu S, Sonmezer M, Atabekoglu C, Berker B, Ozmen B, Isbacar S, Ibis E, Menezes J, Lalitkumar PGL, Borg P, Ekwurtzel E, Nordqvist S, Vaegter K, Tristen C, Sjoblom P, Azevedo MC, Figueira RCS, Braga DPAF, Setti AS, Iaconelli A, Borges E, Remohi Gimenez J, Cobo A, Castello D, Gamiz P, Albert C, Ferreira RC, Braga DPAF, Figueira RCS, Setti AS, Resende S, Iaconelli A, Borges E, Colturato SS, Braga DPAF, Figueira RCS, Setti AS, Resende S, Iaconelli A, Borges E, Ferrer Buitrago M, Ferrer Robles E, Munoz Soriano P, Ruiz-Jorro M, Calatayud Lliso C, Rawe VY, Wanggren K, Hanrieder J, Hambiliki F, Gulen-Yaldir F, Bergquist J, Stavreus-Evers A, Hreinsson J, Grunskis A, Bazarova A, Dundure I, Fodina V, Brikune J, Lakutins J, Pribenszky C, Cornea M, Reichart A, Uhereczky G, Losonczy E, Ficsor L, Lang Z, Ohgi S, Nakamura C, Hagiwara C, Kawashima M, Yanaihara A, Jones GM, Biba M, Kokkali G, Vaxevanoglou T, Chronopoulou M, Petroutsou K, Sfakianoudis K, Pantos K, Perez-Cano I, Gadea B, Martinez M, Muela L, Cruz M, Galindo N, Munoz M, Garrido N, Romano S, Albricci L, Stoppa M, Cerza C, Sanges F, Fusco S, Capalbo A, Maggiulli R, Ubaldi F, Rienzi L, Ulrick J, Kilani S, Chapman M, Losada C, Ortega I, Pacheco A, Bronet F, Aguilar J, Ojeda M, Taboas E, Perez M, Munoz E, Pellicer A, Meseguer M, Boumela I, Assou S, Haouzi D, Monzo C, Dechaud H, Hamamah S, Dechaud H, Boumela I, Assou S, Haouzi D, Monzo C, Hamamah S, Nakaoka Y, Hashimoto S, Amo A, Yamagata K, Nakano T, Akamatsu Y, Mezawa T, Ohnishi Y, Himeno T, Inoue T, Ito K, Morimoto Y. EMBRYOLOGY. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.77] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Sertyel S, Kolankaya A, Yigit A, Cengiz F, Kunacaf G, Akman MA, Gurgan T, Yu B, DeCherney A, Segars J, Russanova V, Howard B, Serafini P, Kimati C, Hassun P, Cuzzi J, Peres M, Riboldi M, Gomes C, Fettback P, Alegretti J, motta E, Lappa C, Ottolini CS, Summers MC, Sage K, Rogers S, Griffin DK, Handyside AH, Thornhill AR, Ubaldi F, Capalbo A, Wright G, Elliott T, Maggiulli R, Rienzi L, Nagy ZP, Cinar Yapan C, Beyazyurek C, Ekmekci CG, Altin G, Yesil M, Yelke H, Kahraman S, Khalil M, Rittenberg V, Khalaf Y, El-toukhy T, Alvaro Mercadal B, Imbert R, Demeestere I, De Leener A, Englert Y, Costagliola S, Delbaere A, Zimmermann B, Ryan A, Baner J, Gemelos G, Dodd M, Rabinowitz M, Hill M, Sandalinas M, Garcia-Guixe E, Jimenez-Macedo A, Gimenez C, Hill M, Wemmer N, Potter D, Keller J, Gemelos G, Rabinowitz M, Cater E, Lynch C, Jenner L, Berrisford K, Campbell A, Keown N, Rouse H, Craig A, Fishel S, Palomares AR, Lendinez Ramirez AM, Martinez F, Ruiz Galdon M, Reyes Engel A, Mamas T, Xanthopoulou L, Heath C, Doshi A, Serhal P, SenGupta SB, Plaza S, Templin C, Saguet F, Claustres M, Girardet A, Rienzi L, Biricik A, Capalbo A, Colamaria S, Bono S, Spizzichino L, Ubaldi F, Fiorentino F, Hassun P, Alegretti JR, Kimati C, Barros B, Riboldi M, Cuzzi J, Motta ELA, Serafini P, Tulay P, Naja RP, Cascales-Roman O, Cawood S, Doshi A, Serhal P, SenGupta SB, Montjean D, Ravel C, Belloc S, Cohen-Bacrie P, Bashamboo A, McElreavey K, Benkhalifa M, Filippini G, Radovanovic J, Spalvieri S, Marabella D, Timperi P, Suter T, Jemec M, Traversa M, Marshall J, Leigh D, McArthur S, Zhang L, Yilmaz A, Zhang XY, Son WY, Holzer H, Ao A, Horcajadas JA, Munne S, Fisher J, Ketterson K, Wells D, Bisignano A, Rubio C, Mateu E, Milan M, Mercader A, Bosch E, Labarta E, Crespo J, Remohi J, Simon C, Pellicer A, Mercader A, Garrido N, Rubio C, Buendia P, Delgado A, Escrich L, Poo ME, Simon C, Held K, Baukloh V, Arps S, Wittmann ST, Petrussa L, Van de Velde H, De Rycke M, Beyazyurek C, Ekmekci CG, Ajredin N, Cinar Yapan C, Tac HA, Yelke HK, Altin G, Kahraman S, Basile N, Bronet F, Nogales MC, Ariza M, Martinez E, Linan A, Gaytan A, Meseguer M, Christopikou D, Tsorva E, Economou K, Davies S, Mastrominas M, Handyside AH, Avo Santos M, M. Lens S, C. Fauser B, S. E. Laven J, B. Baart E, Nakano T, Akamatsu Y, Sato M, Hashimoto S, Maezawa T, Himeno T, Ohnishi Y, Inoue T, Ito K, Nakaoka Y, Morimoto Y, Al Sharif J, Alhalabi M, Abou Alchamat G, Madania A, Khatib A, Kinj M, Monem F, Mahayri Z, Ajlouni A, Othman A, Chung JT, Son WY, Zhang XY, Ao A, Tan SL, Holzer H, Burnik Papler T, Fon Tacer K, Devjak R, Juvan P, Virant-Klun I, Vrtacnik Bokal E, Zheng HY, Chen SL, Chen X, Tang Y, Li L, Ye DS, Yang XH, Eichenlaub-Ritter U, Trapphoff T, Hastreiter S, Haaf T, Asada H, Maekawa R, Tamura I, Tamura H, Sugino N, Zakharova E, Zaletova V, Krivokharchenko I, Ata B, Kaplan B, Danzer H, Glassner M, Opsahl M, Tan SL, Munne S. REPRODUCTIVE (EPI) GENETICS. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.87] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Schimberni M, Ubaldi F, Giallonardo A, Rienzi L, Morgia F, Sbracia M. A controlled trial between natural cycle versus minimal stimulation in poor responder women: minimal stimulation works better in patients less than 40 years old. Fertil Steril 2011. [DOI: 10.1016/j.fertnstert.2011.07.1003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Abstract
During the past decades, improvements in culture of preimplantation embryos have contributed substantially in the success of human assisted reproductive techniques. However, most efforts were focused on optimization of media and gas components, while the established physical conditions and applied devices have remained essentially unchanged. Very recently, however, intensive research has been started to provide a more appropriate environment for the embryos and to replace the rather primitive and inappropriate devices with more sophisticated and practical instruments. Success has been reported with simple or sophisticated tools (microwells or microchannels) that allow accumulation of autocrine factors and establishment of a proper microenvironment for embryos cultured individually or in groups. The microchannel system may also offer certain level of automation and increased standardization of culture parameters. Continuous monitoring of individual embryos by optical or biochemical methods may help to determine the optimal day of transfer, and selection of the embryo with highest developmental competence for transfer. This advancement may eventually lead to adjustment of the culture environment to each individual embryo according to its actual needs. Connection of these techniques to additional radical approaches as automated ICSI or an ultimate assisted hatching with full removal of the zona pellucida after or even before fertilization may result in devices with high reliability and consistency, to increase the overall efficiency and decrease the work-intensity, and to eliminate the existing technological gap between laboratory embryology work and most other fields of biomedical sciences.
Collapse
Affiliation(s)
- L Rienzi
- G.EN.E.R.A. Centre for Reproductive Medicine, Clinica Valle Giulia, Via G. De Notaris 2b, 00197 Rome, Italy.
| | | | | |
Collapse
|
14
|
Rienzi L, Ubaldi F, Barratt C. Session 52: Selection of Male/Female Gametes: Which is More Informative? Debate Session (Basic). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Ubaldi F, Rienzi L. Possible impact of LH-containing gonadotrophins on diploidy rates in preimplantation embryos. Hum Reprod 2009; 24:1238-9; author reply 1239-40. [DOI: 10.1093/humrep/den477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
16
|
Abstract
Methods of selecting gametes before the intracytoplasmic sperm injection (ICSI) technique are of paramount importance, especially where for religious, ethical or legal reasons the production of supernumerary embryos has to be avoided. In these circumstances, in fact, the research has to be focused on the identification of early markers of embryo quality at the oocyte and sperm stage before fertilisation. Oocyte quality can be influenced by several factors such as controlled ovarian hyperstimulation protocols, pharmaceutical preparations and perifollicular vascularisation. Several intracytoplasmic and extracytoplasmic abnormalities have been described, but whether these abnormalities might be predictive of oocyte competence is controversial and the selection methods proposed are still poorly effective. Recently, we have observed that oocyte morphological abnormalities might be indicators of oocyte competence. An abnormal first polar body (but not fragmented), a large perivitelline space, increased cytoplasmic granularity, and the presence of a centrally located granular area seem to have a negative effect on the oocyte potential to fertilise, cleave, and/or develop into a viable embryo. Sperm morphology can be more accurately observed at high magnification using an inverted microscope equipped with Normarski optics (1000x magnification under mineral oil) and a digital system in order to reach a final magnification of approximately 6300x. Single sperm nuclear abnormalities based on strict selection criteria seems to have a clear negative association with ICSI outcome. The possibility of observing the spermatozoa in real time at higher magnification might also be a good opportunity to study the relationship between particular sperm defects and ICSI outcome. In addition to morphology, it has been suggested that spermatozoa selection might be performed on the basis of its biochemical ability to bind to solid hyaluronic acid. However, it must be underlined that prospective randomised studies are necessary to confirm the preliminary results regarding the efficacy of the described criteria proposed, to morphologically select gametes prior to in vitro insemination.
Collapse
Affiliation(s)
- F Ubaldi
- G.EN.E.R.A. Centre for Reproductive Medicine, Valle Giulia Clinic, Via G. De Notaris 2, 00197 Rome, Italy.
| | | |
Collapse
|
17
|
Ubaldi F, Rienzi L, Baroni E, Ferrero S, Iacobelli M, Minasi MG, Sapienza F, Romano S, Colasante A, Litwicka K, Greco E. Hopes and facts about mild ovarian stimulation. Reprod Biomed Online 2007; 14:675-81. [PMID: 17579976 DOI: 10.1016/s1472-6483(10)60667-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Over the last two decades, easier and less expensive stimulation treatments have been largely replaced by more complex and more demanding protocols. Since the mid-nineties, long-term gonadotrophin-releasing hormone agonist stimulation protocols have been widely used. Such lengthy expensive regimens are not free from short- and long-term risks and complications. Mild stimulation protocols reduce the mean number of days of stimulation, the total amount of gonadotrophins used and the mean number of oocytes retrieved. The proportion of high quality and euploid embryos seems to be higher compared with conventional stimulation protocols and the pregnancy rate per embryo transfer is comparable. Moreover, the reduced costs, the better tolerability for patients and the less time needed to complete an IVF cycle make mild approaches clinically and cost-effective over a given period of time. However, further prospective randomized studies are needed to compare cumulative pregnancy rates between the two protocols. Natural cycle IVF, with minimal stimulation, has been recently proposed as an alternative to conventional stimulation protocols in normo- and poor responder patients. Although acceptable results have been reported, further large prospective randomized studies are needed to better evaluate the efficacy of these minimal regimens compared with conventional stimulation approaches.
Collapse
Affiliation(s)
- F Ubaldi
- Centre for Reproductive Medicine, European Hospital, Via Portuense 700-00148 Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
|
19
|
Greco E, Ubaldi F, Rienzi L, Iacobelli M, Ferrero S, Minasi G, Romano S, Litwicka C, Tesarik J. Limiting the number of injected oocytes to three impairs ICSI outcomes in patients with nonobstructive azoospermia. Hum Reprod 2006; 21:1521-4. [PMID: 16459348 DOI: 10.1093/humrep/del001] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Since March 2004, only a maximum of three oocytes were allowed to be subjected to ICSI at one time in Italy. A previous study failed to show an impact of this restriction on fresh embryo transfer outcomes. The objective of this study was to compare ICSI outcomes before and after this restriction in patients with nonobstructive azoospermia. METHODS Patients underwent testicular sperm extraction followed by ICSI. Biological (fertilization rate and the percentage of good-morphology zygotes and embryos) and clinical (clinical pregnancy and implantation rates) outcomes of the last 100 ICSI attempts before the restriction and outcomes of the first 100 ICSI attempts after the restriction were compared. RESULTS Despite comparable fertilization rates (58.8% versus 59.2%; P > 0.05), there was a significant decrease in the percentage of good-morphology zygotes (41.1% versus 88.4%; P < 0.05) and embryos (36.7% versus 74.0%; P < 0.05) in the cohort of embryos transferred, clinical pregnancy rate (22.7% versus 42.4%; P < 0.05) and cumulative pregnancy rate from fresh and frozen embryo transfers (22.7% versus 53.5%; P < 0.05) after the restriction. CONCLUSION The oocyte number restriction reduces dramatically the chance of achieving a clinical pregnancy in cases of nonobstructive azoospermia.
Collapse
Affiliation(s)
- E Greco
- Centre for Reproductive Medicine, European Hospital, Rome, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Greco E, Polonio-Balbi P, Ferrero S, Baroni E, Ubaldi F, Rienzi L, Tesarik J. Use of a fully automated injector for self-administration of follitropin α in an IVF/ICSI programme. Reprod Biomed Online 2005; 11:415-20. [PMID: 16274597 DOI: 10.1016/s1472-6483(10)61132-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Recombinant FSH (r-FSH) used for ovarian stimulation can currently be self-administered either by a conventional syringe or by a pen device. This randomized controlled trial compares the efficacy and convenience of a new, more sophisticated and fully automated injection device (Softinject(trade mark)) with the conventional syringe for r-FSH self-administration. A total of 300 women needing ovarian stimulation for IVF/intracytoplasmic sperm injection were randomized to the automated injector or the conventional syringe group. Patients of both groups had ovarian stimulation with follitropin alpha after pituitary desensitization with a gonadotrophin-releasing hormone agonist. State anxiety score, overall pain score and pregnancy rate were chosen as the main outcome measures. Patients in the automated injector group showed lower state anxiety (P < 0.01) and overall pain (P < 0.01) scores and a comparable pregnancy rate per started cycle as compared with the conventional syringe group. They needed lower doses of r-FSH (P < 0.05) and their stimulation was shorter (P < 0.05). It is concluded that the use of a fully automated injector for r-FSH self-administration reduces pain and stress as compared with the conventional syringe. This device can be used for any subcutaneously administered drug employed in ovarian stimulation.
Collapse
Affiliation(s)
- E Greco
- Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00149 Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
21
|
Rienzi L, Ubaldi F, Martinez F, Minasi MG, Iacobelli M, Ferrero S, Tesarik J, Greco E. Clinical application of laser-assisted ICSI: a pilot study. Eur J Obstet Gynecol Reprod Biol 2004; 115 Suppl 1:S77-9. [PMID: 15196721 DOI: 10.1016/j.ejogrb.2004.01.017] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Human oocyte survival after intracytoplasmic sperm injection (ICSI) can be compromised by abnormal oolemma breakage patterns during the penetration of the microinjection needle. We previously reported a case of repeated ICSI failures associated with abnormal oolemma breakage in which a substantial improvement and successful pregnancy were achieved by performing ICSI through a laser-drilled hole in the zona pellucida (laser-assisted ICSI). This study was undertaken to compare the efficacy of laser-assisted ICSI with that of conventional ICSI in patients whose oocytes present this particular feature. Oocytes treated by laser-assisted ICSI (n=140) survived better (97.9% versus 85.7%; P<0.05) and tended to form more two-pronucleated zygotes (78.6% versus 69.2%; P=0.07) and less zygotes with three or more pronuclei (2.8% versus 7.8%; P=0.06) as compared with sibling oocytes treated by conventional ICSI (n=140). These data show that laser-assisted ICSI is suitable for oocytes with propensity for sudden oolemma breakage during conventional ICSI. The reduction of oocyte damage with laser-assisted ICSI as compared to conventional ICSI may be useful in other clinical indications where only few oocytes are available or when the oocyte survival after ICSI can be supposed to be compromised.
Collapse
Affiliation(s)
- L Rienzi
- Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00149 Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Ubaldi F, Rienzi L, Baroni E, Ferrero S, Iacobelli M, Minasi MG, Sapienza F, Martinez F, Anniballo R, Cobellis L, Tesarik J, Greco E. Cumulative pregnancy rates after transfer of fresh and thawed embryos. Eur J Obstet Gynecol Reprod Biol 2004; 115 Suppl 1:S106-9. [PMID: 15196727 DOI: 10.1016/j.ejogrb.2004.01.022] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Frozen-thawed embryo transfer is an effective procedure that allows further possibilities of pregnancy in addition to those obtained after the fresh in vitro fertilization (IVF). In our follow-up study we analysed all fresh embryo transfer procedures and every frozen-thawed embryo transfer performed from January 2000 to December 2001 evaluating the cumulative pregnancy rates. The study population was divided into two groups according to the female age: <38 years (group I) and >38 years (group II). All the best embryos were chosen for transfer and all the supernumerary good quality embryos were cryopreserved on the day of transfer. The embryos were then thawed and manipulated using a new technique. In group I, 527 patients (619 cycles) underwent fresh embryo transfer and in 232 of them (238 cycles) the embryos were frozen (44% per patients and 38.4% per cycle). In group II, 156 patients (193 cycles) underwent fresh embryo transfer and in 14 of them (15 cycles) the embryos were frozen (9% per patient and 7.8% per cycle). The pregnancy rate of group I patients that had their supernumerary embryos frozen (232 patients and 238 cycles) was 47.4% per cycle and 48.7% per patient whereas in the same population of group II patients (14 patients and 15 cycles) the clinical pregnancy rate was 35.7% per cycle and 38.5% per patients. The cumulative clinical pregnancy rate after transfer of fresh and thawed embryos was: group I, 74% per cycle and 76% per patients; group II, 42.8% per cycle and 46.1% per patient. Frozen-thawed embryo transfer is a cost-effective practice.
Collapse
Affiliation(s)
- F Ubaldi
- Reproductive Medicine, European Hospital, Via Portuense 700, 00148 Rome, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Ubaldi F, Rienzi L, Baroni E, Ferrero S, Iacobelli M, Minasi MG, Sapienza F, Martinez F, Cobellis L, Greco E. Implantation in patients over 40 and raising FSH levels--a review. Placenta 2004; 24 Suppl B:S34-8. [PMID: 14559028 DOI: 10.1016/s0143-4004(03)00179-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
There is an evident decline of female fertility with age. This decline is mainly due to increased risk of pregnancy termination either after conception or after embryo implantation. Very likely the major cause of this embryo and pregnancy loss is chromosomal aneuploidies caused mostly by increasing rates of 'poor quality' oocytes. This phenomenon can be explained either by an age dependent accumulation of damage and/or by the hypothesis that the defective oocytes are there in the ovaries from the fetal life. 'Good quality' oocytes are ovulated first, leaving 'poor quality' oocytes to be ovulated later in life. Besides the quality of the oocytes which is mainly responsible of the embryo quality (we have not to forget a paternal effect) the process of implantation is dependent upon two variables: the probability of a viable embryo and that of a receptive uterine environment. From the oocyte donation model it seems that the endometrium also plays a minor role in human reproductive ageing as it does in some laboratory animals. However, besides some macroscopic possible causes which may play a role in the reduction of the age-related endometrial receptivity, there are so many endometrial factors possibly related to its receptivity which need to be further studied especially in older women.
Collapse
Affiliation(s)
- F Ubaldi
- Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00148 Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Lazzarin N, Valensise H, Bari M, Ubaldi F, Battista N, Finazzi-Agrò A, Maccarrone M. Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle. Gynecol Endocrinol 2004; 18:212-8. [PMID: 15293893 DOI: 10.1080/09513590410001692492] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Abstract
Implantation is possible within a defined period of the menstrual cycle, referred to as the 'implantation window'. It is during this critical period that proper dialog can be established between the blastocyst and a receptive endometrium. If for any reason this dialog is not established or is altered, the embryo is aborted. The factors responsible for the interaction between the embryo and the mother at the moment of implantation remain poorly understood. Recent studies indicate that endocannabinoids may contribute to the development of an adequate milieu at the implantation site. Here we show that the levels of anandamide and of its degrading enzyme, the fatty acid amide hydrolase, in peripheral lymphocytes undergo specific variations during the various phases of the human ovulatory cycle. In particular, we found the highest levels of fatty acid amide hydrolase activity and protein content, paralleled by the lowest anandamide concentrations, in the period that temporally coincides with the putative window of implantation in humans. On the other hand, the anandamide-synthesizing phospholipase D, the anandamide membrane transporter and the anandamide-binding cannabinoid receptors of lymphocytes did not change during the menstrual cycle. This study indicates that high fatty acid amide hydrolase activity and low anandamide levels may be among the factors that co-operate in the success of implantation. This would add to our understanding of the pathophysiological and therapeutic implications of the endocannabinoid system in human fertility.
Collapse
Affiliation(s)
- N Lazzarin
- Department of Obstetrics and Gynecology, University of Rome Tor Vergata, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
25
|
Rienzi L, Martinez F, Ubaldi F, Minasi MG, Iacobelli M, Tesarik J, Greco E. Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004; 19:655-9. [PMID: 14998966 DOI: 10.1093/humrep/deh101] [Citation(s) in RCA: 172] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The clinical efficacy of the current methods used for cryopreservation of metaphase II human oocytes is low. Meiotic spindle disorders are thought to be largely responsible for this situation. METHODS Supernumerary fresh metaphase II human oocytes were cryopreserved in 1,2-propanediol with 0.1 M sucrose using a slow freezing/rapid thawing programme. Meiotic spindles were analysed in these living metaphase II oocytes at sequential steps of the freezing and thawing procedures with the use of a computer-assisted polarization microscopy system (Polscope). RESULTS The meiotic spindle was detected in all 56 oocytes (from 16 patients) before freezing and remained visible in all these oocytes throughout the preparation for freezing up to the time that they were loaded into cryopreservation straws. Immediately after thawing, the spindle was visible in 35.7% of oocytes, but it disappeared in all of the thawed oocytes during the subsequent washing steps. However, the spindle reappeared in all surviving thawed oocytes after washing (57.4%), by 3 h of incubation at 37 degrees C in culture medium. CONCLUSIONS The current techniques of oocyte freezing and thawing inevitably cause meiotic spindle destruction. All spindles observed in thawed oocytes result from post-thaw reconstruction.
Collapse
Affiliation(s)
- L Rienzi
- Centre for Reproductive Medicine, European Hospital, Via Portuense 700, 00149 Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
26
|
Iacobelli M, Greco E, Rienzi L, Ubaldi F, Podini D, Nuccitelli A, Tesarik J, Baldi M, Fiorentino F. Birth of a healthy female after preimplantation genetic diagnosis for Charcot-Marie-Tooth type X. Reprod Biomed Online 2003; 7:558-62. [PMID: 14680548 DOI: 10.1016/s1472-6483(10)62072-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
The X-linked dominant form of Charcot-Marie-Tooth syndrome (CMTX) is a clinically and genetically heterogeneous hereditary disorder of the peripheral nerves caused by mutations in the GJB1 gene that encodes a gap junction protein named connexin 32 (Cx32). Clinically, CMTX is characterized by peripheral motor and sensory deficit with muscle atrophy. A couple with a previous history of pregnancy termination after being diagnosed positive for CMTX by chorionic villus sampling, was referred for preimplantation genetic diagnosis (PGD). The female partner carried the causative H94Q, characterized by a C-->G substitution in codon 94 of exon 2 of the GJB1 gene. Embryos obtained after intracytoplasmic sperm injection (ICSI) were evaluated for the presence of the mother's mutation using polymerase chain reaction (PCR), followed by mutation analysis performed using the minisequencing method. Amelogenin sequences on the X and Y chromosomes were also co-amplified to provide a correlation between embryo gender and mutation presence. A single PGD cycle was performed, involving nine fertilized oocytes, five of which developed into good quality embryos useful for biopsy. Two unaffected embryos were transferred, resulting in a singleton pregnancy followed by the birth of a healthy female.
Collapse
Affiliation(s)
- M Iacobelli
- Reproductive Medicine 'European Hospital', Rome, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Rienzi L, Ubaldi F, Martinez F, Iacobelli M, Minasi MG, Ferrero S, Tesarik J, Greco E. Relationship between meiotic spindle location with regard to the polar body position and oocyte developmental potential after ICSI. Hum Reprod 2003; 18:1289-93. [PMID: 12773461 DOI: 10.1093/humrep/deg274] [Citation(s) in RCA: 111] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND The recent development of a computer-assisted polarization microscopy system (Polscope) with which the meiotic spindle can be visualized in living oocytes on the basis of its birefringence permits analysis of the meiotic spindles of oocytes subjected to ICSI. Previous studies have shown that the meiotic spindle is not always aligned with the first polar body (PB) in metaphase II human oocytes prepared for ICSI. In the present study, the relationship between the degree of meiotic spindle deviation from the first PB location and ICSI outcome was analysed. METHODS Oocytes were divided into four groups according to the angle of meiotic spindle deviation from the PB position. The angle of deviation was 0-5 degrees, 6-45 degrees, 46-90 degrees and >90 degrees for groups I to IV respectively. RESULTS The rates of normal [2 pronuclei (PN)] and abnormal (1PN or >2PN) fertilization did not differ between groups I, II and III. However, the rate of normal fertilization was lower among oocytes in which the meiotic spindle deviation angle was >90 degrees; this led to an increased proportion of tripronucleated zygotes that failed to extrude the second PB. When embryos developed from normally fertilized oocytes were evaluated on day 3 after ICSI, no relationship was found between the angle of meiotic spindle deviation and embryo quality. The meiotic spindle was not detected in only 9% of oocytes, and these showed a higher incidence of fertilization and cleavage abnormalities than did oocytes in which the spindle was detected. When oocytes at metaphase I after cumulus oophorus and corona radiata removal were matured in vitro, the meiotic spindle was detected in 53.8% of those that reached metaphase II. In these in-vitro-matured oocytes the meiotic spindle was always aligned with the first PB, suggesting that misalignment seen in those oocytes matured in vivo resulted from PB displacement during manipulations for cumulus and corona removal. CONCLUSION High degrees of misalignment between the meiotic spindle and the first PB predict an increased risk of fertilization abnormalities. However, when normal fertilization had occurred, the cleavage potential of embryos developing from such oocytes was not impaired. These findings facilitate the selection of oocytes for ICSI in situations when the creation of supernumerary embryos is to be avoided.
Collapse
Affiliation(s)
- L Rienzi
- Centre for Reproductive Medicine, European Hospital, Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
28
|
Ubaldi F. Any effect of adjuvant low dose prednisolone on follicular development and embryo implantation may be masked by the concomitant use of aspirin. Hum Reprod 2003. [DOI: 10.1093/humrep/deg041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
29
|
Ubaldi F, Rienzi L, Ferrero S, Anniballo R, Iacobelli M, Cobellis L, Greco E. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod 2002; 17:1544-7. [PMID: 12042275 DOI: 10.1093/humrep/17.6.1544] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
BACKGROUND Glucocorticoids have been used in conjunction with zona dissection to improve pregnancy and implantation rates in IVF patients. The aim of this prospective randomized study was to evaluate the effect of low-dose prednisolone in addition to the standard protocol, on pregnancy and implantation rates in routine ICSI patients before and after embryo replacement. METHODS A total of 313 patients in 360 consecutive cycles (patients <39 years old and with three or less than three ICSI attempts) performed at our centre were randomly assigned by computer-generated list to receive either prednisolone (10 mg/day in two divided doses), starting on the first day of ovarian stimulation and continuing for 4 weeks (group A), or no treatment (group B). RESULTS The mean age, number of previously failed IVF attempts, basal FSH levels and the mean rank of trials were comparable between groups A and B. The mean (+/- SD) number of metaphase II oocytes retrieved (11.9 +/- 5.5 versus 12.0 +/- 5.1), 2-pronuclei fertilization rate (67.2 versus 65.8%), the pregnancy and the implantation rates were not different between the study and control groups (49.0 and 23.6% versus 50.0 and 23.3% respectively). CONCLUSION Low-dose prednisolone treatment in addition to the standard protocol before and after embryo replacement does not appear to have a significant effect on pregnancy or implantation rates.
Collapse
Affiliation(s)
- F Ubaldi
- Centre for Reproductive Medicine, European Hospital, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
30
|
Abstract
OBJECTIVE To improve oocyte survival and fertilization rates after intracytoplasmic sperm injection (ICSI) in patients with inherent oocyte fragility. DESIGN Pilot feasibility study and case report. SETTING Private hospital. PATIENT(S) Infertile couple with repeated failures of ICSI caused by oocyte degeneration. INTERVENTION(S) Laser-assisted drilling of the zona pellucida followed by ICSI. MAIN OUTCOME MEASURE(S) Oocyte survival, fertilization, and pregnancy. RESULTS In a couple with four previous ICSI failures because of poor oocyte survival (33.3%, 0%, 20%, and 18%), a fifth attempt using laser-assisted ICSI resulted in the survival of 8 oocytes out of 13 injected. Normal fertilization occurred in 5 oocytes, and a clinical pregnancy was established. CONCLUSION(S) Performing ICSI through a laser-drilled hole in the zona pellucida reduces the risk of oocyte damage related to deformation during the initial phase of the microinjection procedure. This modification of ICSI appears to be suitable for patients whose oocyte show inherent fragility and high degeneration rates after the standard ICSI procedure.
Collapse
Affiliation(s)
- L Rienzi
- Center for Reproductive Medicine, European Hospital, Rome, Italy.
| | | | | | | | | | | |
Collapse
|
31
|
|
32
|
Anniballo R, Ubaldi F, Cobellis L, Sorrentino M, Rienzi L, Greco E, Tesarik J. Criteria predicting the absence of spermatozoa in the Sertoli cell-only syndrome can be used to improve success rates of sperm retrieval. Hum Reprod 2000; 15:2269-77. [PMID: 11056118 DOI: 10.1093/humrep/15.11.2269] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
In patients with non-obstructive azoospermia, testicular sperm extraction (TESE) is a method of choice to recover spermatozoa as a male therapeutic approach in intracytoplasmic sperm injection (ICSI) programmes. However, the efficacy of TESE in this indication is burdened by a frequent failure of sperm recovery, which renders useless both the invasive testicular intervention and ovarian stimulation of the patient's spouse. One of the most frequent pathological pictures characterizing complete absence of spermatozoa is germinal aplasia (Sertoli cell- only syndrome or SCOS). Two different histological patterns of SCOS have been already described during the past five decades. These two patterns can be characterized as the congenital (pure) and the secondary (mixed) forms. Both patterns, with different prognosis to retrieve spermatozoa by therapeutic testicular biopsy, are frequently confused when TESE is performed during ICSI programmes. Useful criteria to predict the absence of spermatozoa can be obtained by a definite recognition of the two typical histological patterns during the diagnostic testicular biopsy. The diagnosis of congenital or acquired SCOS can be refined by endocrine, chemical, immunohistochemical and molecular biology aids. Reduction of both sperm retrieval failure and unnecessary ovarian stimulation can be achieved by combination of these methods.
Collapse
Affiliation(s)
- R Anniballo
- Andrology Center 'John McLeod', Via F. Petrarca, Naples, Italy, Center for Reproductive Medicine, European Hospital, Via Portuense, Rome, Italy.
| | | | | | | | | | | | | |
Collapse
|
33
|
Ubaldi F, Rienzi L, Ferrero S, Anniballo R, Greco E, Tesarik J. Sensitivity and Specificity of Wet Preparation Technique in the Detection of Spermatozoa in Therapeutical Testicular Biopsy Samples. Fertil Steril 2000. [DOI: 10.1016/s0015-0282(00)01371-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
34
|
Ubaldi F, Nagy ZP, Rienzi L, Tesarik J, Anniballo R, Franco G, Menchini-Fabris F, Greco E. Reproductive capacity of spermatozoa from men with testicular failure. Hum Reprod 1999; 14:2796-800. [PMID: 10548625 DOI: 10.1093/humrep/14.11.2796] [Citation(s) in RCA: 59] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Controversial reports have been published about the influence of sperm source and of the underlying testicular pathology on success rates of intracytoplasmic sperm injection (ICSI). In this controlled study, ICSI treatment cycles with testicular spermatozoa from men with obstructive and non-obstructive azoospermia were compared with ICSI ejaculated sperm cycles with semen parameters < or = 5 x 10(6)/ml and < or = 10% progressive motility. The control cases were matched for female age, rank of trial, female basal follicle-stimulating hormone serum concentrations and close proximity to the study group's procedure. The fertilization, cleavage, pregnancy and abortion rates were similar in matched groups irrespective of the type of azoospermia. However, the implantation rate in the non-obstructive azoospermic patient group was significantly lower than that in the matched ejaculated sperm group (13.4% versus 26%, P = 0.05). On the other hand, no impairment of the implantation rate was observed in the obstructive azoospermic patient group. These data show that testicular pathology has a negative impact on reproductive performance of testicular spermatozoa, resulting in a decreased implantation potential without any apparent effect on fertilization and early preimplantation development.
Collapse
Affiliation(s)
- F Ubaldi
- Reproductive Medicine, European Hospital, Via Portuense 700, 00149 Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Tesarik J, Greco E, Rienzi L, Ubaldi F, Guido M, Cohen-Bacrie P, Mendoza C. Differentiation of Spermatogenic Cells During In-Vitro Culture of Testicular Biopsy Samples From Patients With Obstructive Azoospermia: Effect of Recombinant Follicle Stimulating Hormone. J Urol 1999. [DOI: 10.1016/s0022-5347(05)68647-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- J. Tesarik
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - E. Greco
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - L. Rienzi
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - F. Ubaldi
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - M. Guido
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - P. Cohen-Bacrie
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| | - C. Mendoza
- Laboratoire d'Eylau, Paris, France, Center of Reproductive Medicine, European Hospital, and Department of Obstetrics and Gynecology, Universita Cattolica del Sacro Cuore, Rome, Italy, and Institute of Biotechnology, University of Granada Faculty of Sciences, Granada, Spain
| |
Collapse
|
36
|
Tesarik J, Greco E, Rienzi L, Ubaldi F, Guido M, Cohen-Bacrie P, Mendoza C. Differentiation of Spermatogenic Cells During In-Vitro Culture of Testicular Biopsy Samples From Patients With Obstructive Azoospermia. J Urol 1999. [DOI: 10.1097/00005392-199908000-00107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
Iacobelli M, Rienzi L, Morgia F, Ubaldi F, Schimberni M, Aragona C, Greco E, Nagy Z. R-127. Poor-quality day 3 embryos can have the potential to develop into viable blastocyst and provide pregnancy after freezing-thawing. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.335-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
38
|
Rienzi L, Ubaldi F, Iacobelli M, Morgia F, Aragona C, Greco E, Nagy Z. R-126. In-vitro fertilization failed-fertilized oocytes can be rescued by intracytoplasmic sperm injection soon after insemination and can result in an ongoing pregnancy. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.335-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
39
|
Ubaldi F, Nagy P, Rienzi L, Anniballo R, Morgia F, Iacobelli M, Ferrero S, Schimberni M, Aragona C, Greco E. P-249. Cessation of gonadotrophin releasing hormone agonist therapy and high dose of menotrophins for ovarian stimulation in low responders. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.265-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Anniballo R, Nagy P, Rienzi L, Morgia F, Iacobelli M, Ferrero S, Schimberni M, Aragona C, Greco E, Ubaldi F. P-030. Predictive value of recovering spermatozoa in frozen-thawed preliminary testicular biopsies in non-obstructed azoospermic patients. Hum Reprod 1999. [DOI: 10.1093/humrep/14.suppl_3.154-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
41
|
Tesarik J, Greco E, Rienzi L, Ubaldi F, Guido M, Cohen-Bacrie P, Mendoza C. Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: effect of recombinant follicle stimulating hormone. Hum Reprod 1998; 13:2772-81. [PMID: 9804229 DOI: 10.1093/humrep/13.10.2772] [Citation(s) in RCA: 60] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Abstract
In-vitro differentiation of spermatogenic cells is a potential approach to the treatment of male sterility due to spermatogenic arrest. This is a pilot study evaluating meiotic, morphogenetic and cytoplasmic maturation of spermatogenic cells from 18 patients with obstructive azoospermia, during in-vitro culture of partly disintegrated testicular biopsy samples in the presence or absence of recombinant follicle stimulating hormone (rFSH). Meiotic progression was detectable only in the presence of rFSH in culture medium. FSH-dependent condensation, peripheral migration and protrusion of spermatid nuclei, together with FSH-independent flagellar growth, were the main events indicating post-meiotic sperm cell differentiation. rFSH also promoted the progression of spermatid cytoplasmic maturation, reflected by acceleration of acrosomal development. These differentiation events appeared to be mediated by humoral activity of Sertoli cells, without the need for a direct Sertoli-sperm cell contact. These findings provide a background for similar studies in patients with non-obstructive azoospermia. If reproducible in the latter group, transmeiotic in-vitro differentiation of primary spermatocytes may be useful in cases of complete maturation arrest, whereas the development of culture-specific forms may help select viable spermatids in cases of complete spermiogenesis failure.
Collapse
|
42
|
Rienzi L, Ubaldi F, Anniballo R, Cerulo G, Greco E. Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod 1998; 13:1014-9. [PMID: 9619563 DOI: 10.1093/humrep/13.4.1014] [Citation(s) in RCA: 102] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
The aim of this study was to examine the relationship between different preincubation periods of oocytes and the outcome of intracytoplasmic sperm injection (ICSI). We analysed retrospectively 95 ICSI treatment cycles performed to alleviate severe male-factor infertility. Oocyte collection was performed approximately 36 h after human chorionic gonadotrophin administration. The cumulus-corona-oocyte complexes obtained were incubated until the moment of ICSI. Fertilization, embryo development and implantation rates were analysed in four groups, which were divided according to the time lapse between oocyte retrieval and ICSI: group I, < or =3 h (18 cycles); group II, >3-< or =6 h (52 cycles); group III, >6-< or =9 h (14 cycles); and group IV, >9-< or =12 h (11 cycles). Immediately before ICSI the cumulus and corona cells were removed from the oocytes. A total of 723 metaphase II oocytes were injected: 126 from group I, 380 from group II, 126 from group III and 91 from group IV. The fertilization rates obtained were 52.3, 66.8, 65.1 and 69.2% respectively [P < 0.05 (using the chi2 test) between group I and groups II, III and IV]. Cleavage rates were similar in all groups (68.1, 69.7, 79.2 and 79.3% respectively), but the proportion of good quality embryos (< or =20% fragmentation) was significantly lower (P < 0.05) in group I (24.2%) compared with groups II (39.8%) and IV (39.6%). However, no statistically significant differences were observed between the four groups with regard to implantation rates (11.7, 13.2, 10.4 and 20.4% respectively). The results suggest that a preincubation period between oocyte retrieval and ICSI can improve the fertilization rate and embryo quality. This period might be necessary for some oocytes to reach full cytoplasmic maturity, leading to a higher activation rate upon microinjection.
Collapse
Affiliation(s)
- L Rienzi
- Reproductive Medicine, European Hospital, Rome, Italy
| | | | | | | | | |
Collapse
|
43
|
Ubaldi F, Wisanto A, Camus M, Tournaye H, Clasen K, Devroey P. The role of transvaginal ultrasonography in the detection of pelvic pathologies in the infertility workup. Hum Reprod 1998; 13:330-3. [PMID: 9557832 DOI: 10.1093/humrep/13.2.330] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
To assess the efficiency of transvaginal ultrasonography (TVUS) in the screening of pelvic pathologies in the initial workup of infertile women, we carried out a prospective comparison of sonographic diagnosis with laparoscopic and pathological findings. Between February 1994 and April 1995, 133 premenopausal non-pregnant women underwent TVUS on the day before laparoscopy. The efficiency of TVUS in detecting pelvic pathologies was 90.2% with a sensitivity of 86.2%, a specificity of 97.8% and positive and negative predictive values of 98.6 and 78.8% respectively. If the six false-negative cases with a histological diagnosis of minimal endometriosis were defined as 'normal pelvis', sensitivity and specificity could be corrected to 92.5 and 98.6% respectively. Endometriomas were diagnosed by TVUS with an efficiency of 96.4%, with a sensitivity and a specificity of 90 and 96.7 % and with positive and negative predictive values of 75 and 99.1% respectively. The sensitivity of vaginal sonographic characterization of pelvic adhesions was 61.1% with a specificity and positive predictive value of 98.2 and 84.6%. The negative predictive value of TVUS was 94.1%. These data suggest that it is not possible to characterize pelvic adhesions, especially filmy adhesions, with acceptable accuracy. However, in the initial workup of infertile women, if the patient is young, if both hysterosalpingography and TVUS are negative, laparoscopy could be postponed. In couples with severe male factor infertility and for whom in-vitro fertilization or intracytoplasmic sperm injection is the treatment of choice, laparoscopy might be avoided where the TVUS is negative.
Collapse
Affiliation(s)
- F Ubaldi
- Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Belgium
| | | | | | | | | | | |
Collapse
|
44
|
Aytoz A, Tournaye H, Camus M, Ubaldi F, Verheyen G, Van Steirteghem A, Devroey P. Is there any need for diagnostic laparoscopy in couples undergoing intracytoplasmic sperm injection for severe male-factor infertility. J Assist Reprod Genet 1998; 15:79-83. [PMID: 9513846 PMCID: PMC3455423 DOI: 10.1007/bf02766830] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
PURPOSE Our purpose was to determine whether there is a need for a preliminary diagnostic laparoscopy in couples undergoing intracytoplasmic sperm injection (ICSI) because of severe male-factor infertility. METHODS In this retrospective study, the results of diagnostic laparoscopy in 342 women with a normal fertility workup undergoing ICSI were evaluated and sperm parameters were correlated with the findings at laparoscopy. Subgroups of patients were defined according to sperm quality, which was expressed as total normal motile count [TNMC = volume (ml) x concentration (10(6)/ml) x percentage progressive motility/100 x percentage normal morphology/100]. RESULTS When sperm morphology was evaluated according to Kruger's strict criteria, the probability of finding pathology on laparoscopy in the normal male group (16.7%) was statistically higher than that in the group with severely abnormal sperm (1.8%; P < 0.01). CONCLUSIONS There is no need to perform a preliminary diagnostic laparoscopy in the female partner if a full workup is normal in couples with severe male-factor infertility willing to undergo ICSI.
Collapse
Affiliation(s)
- A Aytoz
- Center for Reproductive Medicine, University Hospital and Medical School, Dutch-speaking Brussels Free University, Belgium
| | | | | | | | | | | | | |
Collapse
|
45
|
Aytoz A, Ubaldi F, Tournaye H, Nagy ZP, Van Steirteghem A, Devroey P. The predictive value of uterine artery blood flow measurements for uterine receptivity in an intracytoplasmic sperm injection program. Fertil Steril 1997; 68:935-7. [PMID: 9389829 DOI: 10.1016/s0015-0282(97)00333-6] [Citation(s) in RCA: 41] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE To assess whether uterine artery blood flow impedance, measured as the pulsatility index on the day of ET in patients undergoing IVF-ET with microinjection, can predict the likelihood of pregnancy. DESIGN Prospective clinical study. SETTING A tertiary referral center for assisted reproduction. PATIENT(S) Seventy patients undergoing intracytoplasmic sperm injection (ICSI) for andrologic indications. INTERVENTION(S) Transvaginal color Doppler examination performed on the day of ET. MAIN OUTCOME MEASURE(S) Mean (+/- SD) pulsatility index value of the left and right uterine arteries, serum E2 levels, implantation rates, and ongoing pregnancy rates (PRs). RESULT(S) The patients were divided into pregnant and nonpregnant groups and were separated according to whether the pulsatility index was low (1.00-1.99), medium (2.00-2.99), or high (> or = 3.00). The pulsatility index values did not change statistically in the pregnant and nonpregnant groups. The implantation rates were 19.5%, 15.4%, and 25% for the low-, medium-, and high-pulsatility index groups, respectively. The ongoing PRs for the same groups were 35.3%, 26.7%, and 37.5%, respectively. CONCLUSION(S) The study suggests that blood flow, measured as the pulsatility index on the day of ET, cannot predict the likelihood of pregnancy in stimulated cycles of ICSI.
Collapse
Affiliation(s)
- A Aytoz
- Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Belgium
| | | | | | | | | | | |
Collapse
|
46
|
Rienzi L, Ubaldi F, Anniballo N, Cerulo G, Greco E. P-133. Preincubation of oocytes may improve fertilization rates after ICSI. Hum Reprod 1997. [DOI: 10.1093/humrep/12.suppl_2.183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril 1997; 67:521-6. [PMID: 9091341 DOI: 10.1016/s0015-0282(97)80080-5] [Citation(s) in RCA: 185] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE To investigate the effect of subtle serum P rise before hCG administration on endometrial maturation in stimulated cycles. DESIGN Case-control study. SETTING Tertiary referral center. PATIENT(S) Twenty patients with serum P < or = 0.9 ng/mL (group I) (conversion to SI unit, 3.180), 20 patients with premature P rise (> or = 1.1 ng/mL, group II), and 20 patients with normal serum P (group III). INTERVENTION(S) Patients in groups I and II underwent endometrial aspiration biopsies on the day of oocyte retrieval in the ET cycles themselves. Patients in group III, without endometrial biopsies, were chosen as controls. MAIN OUTCOME MEASURE(S) Comparison of endometrial maturation, correlation between endometrial dating and cumulative P exposure, and/or number of days of P > or = 1.1 ng/mL and comparison of clinical outcome. RESULT(S) Groups I and II showed a secretory activity of the endometrium. In group II, the endometrial dating correlated neither with P exposure nor with the number of days of subtle P rise. Clinical pregnancies were observed in both groups but none in cases with endometrium advanced > 3 days. Similar pregnancy and implantation rates were observed between groups I and III. CONCLUSION(S) These data suggest that an endometrial aspiration biopsy performed on the day of oocyte retrieval may be used to assess endometrial receptivity in patients with serum P rise.
Collapse
Affiliation(s)
- F Ubaldi
- Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Brussels, Belgium
| | | | | | | | | | | |
Collapse
|
48
|
Ubaldi F, Nagy Z, Janssenwillen C, Smitz J, Van Steirteghem A, Devroey P. Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. Hum Reprod 1997; 12:454-6. [PMID: 9130739 DOI: 10.1093/humrep/12.3.454] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
This case illustrates the possibility of obtaining oocytes that fertilize and cleave normally after the administration of a second ovulatory dose of human chorionic gonadotrophin (HCG) in a case of 'empty follicle syndrome'. The present patient underwent ovarian stimulation with gonadotrophin-releasing hormone analogue (GnRHa)/menotropin for intracytoplasmic sperm injection (ICSI). After the failure of the first oocyte retrieval, a second dose of HCG was administered to trigger ovulation. A total of 13 oocytes was retrieved during the second procedure and 11 good quality embryos were obtained (fertilization and cleavage rates of 92 and 91% respectively). No pregnancy was achieved after the replacement of three embryos. In a subsequent cycle stimulated with clomiphene citrate, three frozen-thawed embryos were replaced and a twin pregnancy was achieved. The patient delivered two healthy babies at term.
Collapse
Affiliation(s)
- F Ubaldi
- Center for Reproductive Medicine, Dutch-Speaking Brussels Free University, Belgium
| | | | | | | | | | | |
Collapse
|
49
|
Tournaye H, Verheyen G, Nagy P, Ubaldi F, Goossens A, Silber S, Van Steirteghem AC, Devroey P. Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? Hum Reprod 1997; 12:80-6. [PMID: 9043908 DOI: 10.1093/humrep/12.1.80] [Citation(s) in RCA: 273] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Recovery of testicular spermatozoa from azoospermic patients with testicular failure followed by intracytoplasmic sperm injection (ICSI) is a recent advance in the treatment of male infertility. This study aimed at investigating which parameter(s) may predict successful testicular sperm recovery. We reviewed 395 testicular sperm recovery procedures and analysed the most frequently available parameters for clinical decision-making in azoospermic patients: (i) presence of at least one single spermatozoon in at least one preliminary semen analysis; (ii) maximum testicular volume; (iii) serum follicle stimulating hormone (FSH); and (iv) presence of spermatozoa in the histology of a randomly-taken testicular biopsy. Sensitivity, specificity, positive and negative predictive value, positive and negative likelihood ratio and accuracy were calculated for the above index parameters in different clinically relevant subgroups using receiver operating characteristic (ROC) curves whenever possible. Spermatozoa were always successfully recovered in patients with normal testicular histological findings (n = 173) or hypospermatogenesis (n = 16) but not in some patients with tubular sclerosis (seven out of 18), Sertoli cell-only pattern (55 out of 112) or maturation arrest (39 out of 76). Histopathology was the best test for predicting successful sperm recovery in the whole population (sensitivity: 86%, specificity: 93%, accuracy: 0.87). In patients with secretory azoospermia, histopathology was again the most accurate parameter (accuracy: 0.74), especially in patients showing Sertoli cell-only pattern (accuracy: 0.83) but not in patients showing maturation arrest (accuracy: 0.55). In patients with serum FSH concentrations > 12 IU/l and maximum testicular volume < 15 ml, histopathology was not found to be accurate. Semen analysis, maximum testicular volume and serum FSH were not highly predictive in all subgroups studied. Our analysis shows that no strong predictors for successful testicular sperm recovery are available except for testicular histopathology.
Collapse
Affiliation(s)
- H Tournaye
- Centre For Reproductive Medicine, University Hospital, Dutch-speaking Brussels Free University
| | | | | | | | | | | | | | | |
Collapse
|
50
|
Tournaye H, Camus M, Ubaldi F, Clasen K, Van Steirteghem A, Devroey P. Tubal transfer: a forgotten ART? Is there still an important role for tubal transfer procedures? Hum Reprod 1996; 11:1815-8. [PMID: 8921040 DOI: 10.1093/oxfordjournals.humrep.a019493] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Affiliation(s)
- H Tournaye
- Centre for Reproductive Medicine, University Hospital of the Dutch-speaking Brussels Free University, Belgium
| | | | | | | | | | | |
Collapse
|